Abstract:DEAR EDITOR, Enlarged pores are a common cosmetic concern. Although nonablative fractional lasers (NAFLs) have been used to reduce enlarged facial pores, a prospective, split-face, controlled study with objective assessment is lacking. A 1565-nm NAFL (M22 ResurFX; Lumenis, Yokneam, Israel) has proved effective on skin elasticity and stretch marks; therefore, we aimed to assess its safety and efficacy on enlarged facial pores. The present study was approved by the investigational review board of the Shanghai Ninth People’s Hospital (clinical trials registration number ChiCTR-ONh-16009094). We initially estimated an improvement of 40% on the treated side of the face vs. the nontreated side. To estimate sample size, we tested the null hypothesis that there would be a decrease of ≤ 10% in the number of enlarged pores between both sides of the face. With a sample size of 17, a 40% difference between the two sides would refute this hypothesis with a power of 80% and a 2 5% level of significance. In total, 22 participants with increased seborrhoea and enlarged pores were enrolled. Seventeen patients completed the study and five dropped out. Complaints of pain or oedema and personal reasons accounted for the dropouts. Based on a computer-generated randomization list, one side of the face was treated and the other side served as the control (Fig. 1a; further images are available from the corresponding author upon request). EMLA (Astra Pharmaceuticals, Oslo, Norway), a topical anaesthetic ointment (containing 25 mg lidocaine and 25 mg prilocaine), was applied 1 h before treatment. Spots measuring 17 mm with integrated contact cooling were used. A 38–40 mJ per microbeam laser was used for the first pass and 20–24 mJ per microbeam for the second; density was 300 microbeams per cm for both passes. The same parameters were used for a total of four treatments carried out at 2-week intervals. The quantitative number of pores was automatically calculated with the VISIA-CR imaging system (Canfield Scientific, Fairfield, NJ, U.S.A.) before treatment and 2 months after the final treatment. The device detects pores using an algorithm designed to detect circular objects of 0 4–1 0 mm in diameter. Feature analysis only occurs within automatically targeted zonal mask regions representing the best view, thereby reducing variability due to the camera angle. Use of the NAFL significantly decreased the number of facial pores (P < 0.001) post-treatment. The total average number of facial pores was 1015 on the NAFL-treated side and 1012 on the untreated side; these numbers decreased to 631 and 848, respectively, at the 2-month follow-up. The average pore reduction rate was 41 1% for the NAFL side and 16 5% for the untreated side (Fig. 1b–f). Missing data were not included. Participants were asked to rate the degree of pain immediately post-treatment using a visual analogue scale (VAS) ranging from 0 (no pain at all) to 10 (unbearable pain). Pain was reported as mild to moderate with a mean SD VAS score of 4 75 1 23. Other adverse events included immediate slightto-moderate erythema and oedema (100%), which continued for 2–4 days post-treatment. No permanent side-effects were seen. Compared with traditional ablative procedures, such as the CO2 fractional laser or the erbium–yttrium aluminum garnet fractional laser, NAFL allows for quicker healing with minimal downtime, low treatment discomfort and relatively fewer side-effects. Enlarged pores have been treated with an increasing focus on increased seborrhoea rather than as a component of photoageing. Only mild improvement of facial pores has been observed using a 1064-nm neodymium-doped yttrium aluminum garnet laser. Recently, NAFLs were introduced for skin resurfacing. Compared with the 1550/1540-nm laser, the 1565-nm NAFL has similar water absorption features. However, the newest CoolScan technique, as well as its integrated contact cooling system, has limited the bulk heating to the dermis, making it safer for sensitive or darker skin than other NAFLs. The ‘bystander effect’ may have contributed to the decrease of pores on the untreated side of the face. In the absence of any direct heating, heat diffusion or cell-to-cell contact, ‘bystander’ cells experience DNA damage, apoptosis and loss of viability when sharing the medium with heat-exposed cells. This is mostly found in dividing cells. We hypothesize that both bystander effects and an improvement in patient lifestyle contributed to skin resurfacing on the untreated sides of the face. The present study is the first split-face controlled trial using a 1565-nm NAFL with objective measurements for treating facial pores. Limitations include the low number of participants and the relatively brief follow-up period. The preliminary data show that a 1565-nm NAFL is significantly effective

Fractional microneedle radiofrequency device and fractional erbium-doped glass 1,565-nm device treatment of human facial photoaging: a prospective, split-face, random clinical trial

Microneedle fractional radiofrequency treatment of facial photoageing as assessed in a split‐face model

Microneedle fractional radiofrequency associated with drug delivery for facial atrophic acne scars and skin rejuvenation

Efficacy and safety of 1565-nm non-ablative fractional laser versus long-pulsed 1064-nm Nd:YAG laser in treating enlarged facial pores

Curative effects of microneedle fractional radiofrequency system on skin laxity in Asian patients: A prospective, double-blind, randomized, controlled face-split study

A randomized, split-face controlled trial on the safety and effects of microneedle fractional radiofrequency and fractional erbium-doped glass 1,565-nm laser therapies for baggy lower eyelids

Facial tightening using a novel vacuum‐assisted microneedle fractional radiofrequency system: A prospective, randomized, split‐face study

An optimized intense pulsed light combined with a non-ablative 1 565 nm fractional laser for facial rejuvenation: a randomized, controlled, split-face study

The Efficacy and Safety of Radiofrequency Microneedling Versus a Nonablative Fractional 1,550-nm Erbium:Glass Laser for the Rejuvenation of the Neck

Randomized Split-Face, Controlled Comparison of Treatment with 1565-Nm Nonablative Fractional Laser for Enlarged Facial Pores

Comparison of Fractional Micro-Plasma Radiofrequency and Fractional Microneedle Radiofrequency for the Treatment of Atrophic Acne Scars: A Pilot Randomized Split-Face Clinical Study in China

A prospective, randomized, double-blind comparison of an ablative fractional 2940-nm erbium-doped yttrium aluminum garnet laser with a nonablative fractional 1550-nm erbium-doped glass laser for the treatment of photoaged Asian skin

Can Microneedle Fractional Radiofrequency System Treatment Impair the Skin Barrier Function in Chinese Patients? A Prospective Clinical Trial

Efficiency and safety of microneedling fractional radiofrequency in the treatment of Chinese atrophic acne scars: A retrospective study of 3 consecutive treatments with 1-month intervals

Microneedling Radiofrequency Enhances Poly-L-lactic Acid Penetration That Effectively Improves Facial Skin Laxity Without Lipolysis

Hyaluronic Acid Dissolving Microneedles and Nonablative Fractional Laser for Infraorbital Wrinkles: A Prospective, Randomized, Split-Face Study

A retrospective study of non-insulated microneedle radiofrequency on wrinkles of facial photoaging subjects

Effectiveness and Safety of Nonablative Fractional Laser and Infrared Bipolar Radiofrequency for Treating Periorbital Wrinkles

Full‐face and neck resurfacing with a novel ablative fractional 2910 nm erbium‐doped fluoride glass fiber laser for advanced photoaging

CHINESE EXPERIENCE OF FRACTIONAL ULTRAPULSED CO2 LASER FOR SKIN REJUVENATION

Comparison of 1064-nm Nd:YAG picosecond laser using fractional micro-lens array vs. ablative fractional 2940-nm Er:YAG laser for the treatment of atrophic acne scar in Asians: a 20-week prospective, randomized, split-face, controlled pilot study